Dc638251 B0c4 46b0 B3b4 07c10c50e94a 00
Duloxetine Hydrochloride
Product Images NDC 63187-457
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Duloxetine Hydrochloride (NDC 63187-457). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Structure (Duloxetinedrcapsules Figure 01)
1 (Duloxetinedrcapsules Figure 02)
The text describes a chart that shows various levels of pain relief achieved by patients of different doses of duloxetine and placebo. The chart has a horizontal axis marked with percentage values for improvement in pain, and a vertical axis marked with four different doses of duloxetine and placebo. However, there is no further information or context provided about the chart or what it represents.*
2 (Duloxetinedrcapsules Figure 03)
The text describes a chart showing the percentage of patients who experienced various levels of pain relief as measured by the 24-hour average pain severity. The chart compares the effects of Duloxetine 60 mg BID and Duloxetine 60 mg QD to a placebo.*
Graph (Duloxetinedrcapsules Figure 04)
The given text seems to be a figure or graph rather than a description. Thus, the required information or context could not be derived from the text.*
Figure 6 (Duloxetinedrcapsules Figure 05)
Graph (Duloxetinedrcapsules Figure 06)
The text provides a graph (Figure 7) that shows the percentage of patients who achieved various levels of pain relief as measured by 24-hour average pain severity. The relief is due to taking either placebo (with 100% improvement) or Duloxetine at 60/120 mg once daily. The measurement was conducted on patients with OA-1.*
Logo (Duloxetinedrcapsules Figure 07)
Logo (Duloxetinedrcapsules Figure 08)
Image 01
This is a medication with the National Drug Code 63187-457-30 indicated for oral administration by prescription only. It is Duloxetine 60mg, the product ID is RD045730 and it is manufactured by Torrent Pharmaceuticals LTD in India. It comes in a container with 30 hard gelatin capsules, each containing 67.36mg of duloxetine hydrochloride. The capsules have an opaque blue cap and a yellow body and are imprinted with '60 mg' and '1111'. The medication should be kept out of the reach of children and stored at 20°-25°C (68°-77°F). Additionally, it has been relabeled by Proficient Rx LP in Thousand Oaks, CA 91320.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
